Affiliations: [a] Université Paris Descartes, Paris, France
| [b] Gliaxone, Saint Germain Sous Doue, France
| [c] Formerly at: School of Information Systems, Technology and Management, University of New South Wales, UNSW Sydney, Australia
| [d] Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA
| [e] Université Paris Descartes, Faculté de Chirurgie Dentaire, Hôpital Bretonneau, HUPNVS, AP-HP, Paris, France
Correspondence:
[*]
Correspondence to: Claude Robert, Gliaxone, 30 rue de la Fontaine, 77 169 Saint Germain Sous Doue, France. E-mail: [email protected].
Abstract: This study surveys the development of Alzheimer’s disease (AD) in the research literature, the scientific community, and the journals containing AD papers over a 35-year period. Research papers on AD published from 1983 to 2017 in journals indexed in the Web of Science were analyzed in seven five-year periods. The number of AD papers increased from 1,095 in 1983–1987 to 50,532 by 2013–2017 and in the same time period, the number of participating countries went from 27 to 152. The US was the most prolific country throughout, followed by several European countries, Canada, Australia, and Japan. Asian countries have emerged and by 2013–2017, China surpassed all but the US in productivity. Countries in Latin America and Africa have also contributed to AD research. Additionally, several new non-governmental institutions (e.g., ADNI, ADI) have emerged and now play a key role in the fight against AD. Likewise the AD scientific publishing universe evolved in various aspects: an increase in number of journals containing AD papers (227 journals in 1983–1987 to 3,257 in 2013–2017); appearance of several AD-focused journals, e.g., Alzheimer’s & Dementia, Journal of Alzheimer’s Disease; and the development of special issues dedicated to AD. Our paper complements the numerous extant papers on theoretical and clinical aspects of AD and provides a description of the research landscape of the countries and journals contributing papers related to AD.
Keywords: AD institutions, Alzheimer’s disease, bibliometrics, country contribution, journal analysis, publication growth
